Product Code: ETC8846596 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The treatment market for neurodegenerative diseases is driven by innovations in pharmaceuticals, stem cell therapy, and neuroprotective agents. The Philippines is seeing increased investment in healthcare infrastructure and drug development, particularly for disease-modifying therapies. Improved access to diagnostics is also enabling earlier intervention.
The rising need for innovative treatment solutions for neurodegenerative diseases fuels the market in the Philippines. Increasing investments in regenerative medicine, stem cell therapies, and neuroprotective drugs are driving market expansion. Additionally, improved healthcare accessibility and specialized neurology centers contribute to the availability of advanced treatment options.
The neurodegenerative disease treatment market is constrained by limited drug availability and slow adoption of advanced treatment approaches. Many disease-modifying therapies used in developed countries are not yet widely available in the Philippines. Furthermore, the high cost of long-term treatment creates financial burdens for patients and their families.
The rising prevalence of neurodegenerative diseases such as Alzheimer`s, Parkinsons, and multiple sclerosis in the Philippines has created a strong demand for advanced treatment options. The market offers investment opportunities in pharmaceutical research, innovative drug therapies, and the expansion of specialized healthcare facilities. Companies can explore collaborations with local healthcare providers to enhance early diagnosis and treatment accessibility. Additionally, investments in telemedicine and digital health solutions can improve patient management and monitoring, making care more efficient and widely available.
Policies emphasize the availability of treatment for neurodegenerative diseases through government-funded healthcare programs. The inclusion of neurodegenerative drugs in insurance coverage ensures affordability. The government also collaborates with pharmaceutical companies to facilitate clinical trials for advanced treatments.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Neurodegenerative Disease Treatment Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Neurodegenerative Disease Treatment Market - Industry Life Cycle |
3.4 Philippines Neurodegenerative Disease Treatment Market - Porter's Five Forces |
3.5 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Drug Type:, 2021 & 2031F |
3.7 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Route of Administration:, 2021 & 2031F |
3.8 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Distribution Channel:, 2021 & 2031F |
4 Philippines Neurodegenerative Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Neurodegenerative Disease Treatment Market Trends |
6 Philippines Neurodegenerative Disease Treatment Market, By Types |
6.1 Philippines Neurodegenerative Disease Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.4 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.1.5 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.1.6 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Spinal Muscular Atrophy (SMA), 2021- 2031F |
6.1.7 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Huntingtons Disease, 2021- 2031F |
6.1.8 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Neurodegenerative Disease Treatment Market, By Drug Type: |
6.2.1 Overview and Analysis |
6.2.2 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F |
6.2.3 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Selective Serotonin Reuptake Inhibitors, 2021- 2031F |
6.2.4 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Dopamine Inhibitors, 2021- 2031F |
6.2.5 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Philippines Neurodegenerative Disease Treatment Market, By Route of Administration: |
6.3.1 Overview and Analysis |
6.3.2 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Neurodegenerative Disease Treatment Market, By Distribution Channel: |
6.4.1 Overview and Analysis |
6.4.2 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Philippines Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Neurodegenerative Disease Treatment Market Import-Export Trade Statistics |
7.1 Philippines Neurodegenerative Disease Treatment Market Export to Major Countries |
7.2 Philippines Neurodegenerative Disease Treatment Market Imports from Major Countries |
8 Philippines Neurodegenerative Disease Treatment Market Key Performance Indicators |
9 Philippines Neurodegenerative Disease Treatment Market - Opportunity Assessment |
9.1 Philippines Neurodegenerative Disease Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Philippines Neurodegenerative Disease Treatment Market Opportunity Assessment, By Drug Type:, 2021 & 2031F |
9.3 Philippines Neurodegenerative Disease Treatment Market Opportunity Assessment, By Route of Administration:, 2021 & 2031F |
9.4 Philippines Neurodegenerative Disease Treatment Market Opportunity Assessment, By Distribution Channel:, 2021 & 2031F |
10 Philippines Neurodegenerative Disease Treatment Market - Competitive Landscape |
10.1 Philippines Neurodegenerative Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 Philippines Neurodegenerative Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |